| GO Term | Fold Change | Genes |
| apoptosome | 552.30 | APAF1,CASP9 |
| activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c | 220.92 | APAF1,CASP9 |
| TORC2 complex | 207.11 | MAPKAP1,RICTOR,MLST8 |
| Bcl-2 family protein complex | 184.10 | BAK1,MCL1,BCL2L11 |
| TOR signaling | 78.90 | MAPKAP1,RICTOR,MLST8,LAMTOR4,FLCN |
| positive regulation of mitochondrial membrane permeability | 59.18 | BAK1,VDAC2,BCL2L11 |
| positive regulation of membrane permeability | 53.45 | BAK1,VDAC2,BCL2L11 |
| extrinsic apoptotic signaling pathway in absence of ligand | 51.78 | BAK1,MCL1,BCL2L11 |
| signal transduction in absence of ligand | 51.78 | BAK1,MCL1,BCL2L11 |
| apoptotic mitochondrial changes | 39.45 | BAK1,VDAC2,MCL1,BCL2L11 |
| intrinsic apoptotic signaling pathway in response to DNA damage | 31.12 | BAK1,MCL1,CASP9,BCL2L11 |
| intrinsic apoptotic signaling pathway | 20.71 | BAK1,APAF1,MCL1,CASP9,BCL2L11,FLCN |
| regulation of TOR signaling | 20.46 | RICTOR,MLST8,LAMTOR4,FLCN,MAPKAPK5 |
| mitochondrial outer membrane | 16.01 | MARCHF5,BAK1,VDAC2,MCL1,BCL2L11,THG1L |
| regulation of intrinsic apoptotic signaling pathway | 15.96 | UBQLN1,VDAC2,MCL1,BCL2L11,FLCN |
| organelle outer membrane | 14.10 | MARCHF5,BAK1,VDAC2,MCL1,BCL2L11,THG1L |
| outer membrane | 13.92 | MARCHF5,BAK1,VDAC2,MCL1,BCL2L11,THG1L |
| apoptotic signaling pathway | 12.55 | BAK1,VDAC2,APAF1,MCL1,CASP9,BCL2L11,FLCN |
| mitochondrial membrane | 6.27 | MARCHF5,BAK1,VDAC2,MCL1,BCL2L11,THG1L,ALAS1,HCCS |